BioMark Diagnostics Inc BMKDF
$0.36 $0.00 (0.08%) 1D
Last Updated: Aug 21, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
BMKDF Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, BioMark Diagnostics Inc is classified as halal.
HALAL
Report Source: undefined Quarter Report
BioMark Diagnostics Inc. Stock Analysis BMKDF
United States N/A Nano Cap BioMark Diagnostics, Inc. is a canadian-based company, which engages in the development and commercialization of cancer diagnostic solutions to detect, monitor, and assess treatment for cancer. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2014-11-03. The firm's proprietary technology utilizes a simple blood draw to detect the presence of cancer-associated biomarkers, enabling earlier diagnosis and improved patient outcomes. Its cancer diagnostics technology platform leverages Omics and machine learning with a focus on cancers that are hard to detect and treat. The technology can also be used for measuring response to treatment and potentially for serial monitoring of cancer survivors. The company is also engaged in developing accessible diagnostic solutions to address unmet medical needs in oncology. Its liquid biopsy assay detects Spermidine/spermine N-acetyltransferase 1 (SSAT1). SSAT1 is an enzyme with elevated levels in numerous cancers. Its oncology has developed a liquid biopsy metabolic panel assay, which is instrumental for early-stage diagnosis of lung cancer.
BioMark Diagnostics Inc (BMKDF) Chart
Financial Metrics & Statements of BioMark Diagnostics Inc (BMKDF)
FAQ's for BioMark Diagnostics Inc (BMKDF)
- As of August 2026, BioMark Diagnostics Inc BMKDF is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BioMark Diagnostics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in BioMark Diagnostics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of BioMark Diagnostics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of BioMark Diagnostics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of BioMark Diagnostics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to BioMark Diagnostics Inc (BMKDF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
